Evidence map›Paper›PMID 34497449›Full record

ArticleWorld journal of gastroenterology2021

Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle.

Artem Mashukov, Dmytro Shapochka, Oleksii Seleznov, Nazarii Kobyliak, Tetyana Falalyeyeva, Stanislav Kirkilevsky, Roman Yarema, Oksana Sulaieva

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Artem MashukovDepartment of Oncology, Odessa National Medical University, Odessa 65082, Ukraine.
Dmytro ShapochkaDepartment of Molecular Pathology and Genetics, Medical Laboratory CSD, Kyiv 03022, Ukraine.
Oleksii SeleznovDepartment of Pathology, Medical Laboratory CSD, Kyiv 03022, Ukraine.
Nazarii KobyliakDepartment of Pathology, Medical Laboratory CSD, Kyiv 03022, Ukraine.
Tetyana FalalyeyevaBiomedicine, Educational-Scientific Center, "Institute of Biology and Medicine" Taras Shevchenko National University of Kyiv, Kyiv 01601, Ukraine.
Stanislav KirkilevskyDepartment of Thoracic Tumors, National Cancer Institute, Kyiv 03022, Ukraine.
Roman YaremaDepartment of Oncology and Medical Radiology, Danylo Halytsky Lviv National Medical University, Lviv 79010, Ukraine.
Oksana SulaievaDepartment of Pathology, Medical Laboratory CSD, Kyiv 03022, Ukraine.
Kyiv Medical University · UADanylo Halytsky Lviv National Medical University · UAInstitute of Molecular Biology and Genetics · UANational Cancer Institute · UAOdessa National Medical University · UATaras Shevchenko National University of Kyiv · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete.

aimTo clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept.

methodsIn total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated.

resultsWe found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters.

conclusionThese data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management.

Indexed as

CarcinomaStomach NeoplasmsB7-H1 AntigenCell DifferentiationHumansLymphocytes, Tumor-InfiltratingTumor MicroenvironmentB7-H1 AntigenGastric carcinomaTumor associated macrophagesTumor immune microenvironmentTumor infiltrating lymphocytes

Identifiers

PMID34497449
PMCPMC8384749
OpenAlexW3195961207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.